News
Interesting
news on our website and our activities
Internships
From September 2008 we have two trainee-positions available including research and development experimental projects for biotechnology-, molecular biology-, or biomedical students. The projects focus on White Biotechnology related developments using Industrial Micro-organisms to produce specific (recombinant)proteins or fine chemicals. For more information please contact us at research@imenz.com.
Internships
From January 2008 we have two trainee-positions (internships) available for biotechnology-, molecular biology-, or biomedical students. For more information please contact us at research@imenz.com.
BIOPRODUCTIONValue creation from organic byproducts.
IMEnz Bioengineering BV has recently started with the EU funded research on the sustainable Microbial and Biocatalytic Production of Advanced Functional Materials. The project aims at the development of novel sustainable bioprocesses for the production of functional biochemicals (e.g., lactic acid- and PHA-based polyesters, chitosan and alginate biopolymers, polysaccharide-based biosurfactants).
In the coming 3.5 years it is aimed to select and develop enzymes and bacterial strains that catalyse processes to create value from organic matter. The products (biochemicals) will more and more replace the currently produced chemicals from mineral oils. With these activities IMEnz Bioengineering will importantly contribute not only to a better and cleaner environment, but will also develop processes to create value from agricultural sources. See: www.bioproduction.org for further information or contact us at research@imenz.com.
New technology for the discovery of anti-microbial compounds
During the last decades there has been a tendency that indicates a decreased effectiveness of administered antibiotics to conquer undesired bacterial growth. The occurrence and proliferation of undesired micro-organisms is one of the major problems in the production of food and can lead to spoilage and significant economic loss. Furthermore, the growth of pathogens, e.g. during the manufacturing of pharmaceutical products, is becoming a major issue.
In addition, novel legislation limits the use of many anti-microbial agents in food preparations. Thus, milder and safer doses of, preferably, more natural anti-microbials are sought for. To that goal, the so-called ‘hurdle-technology’ in which combinations of different (natural) compounds are applied, could offer an attractive alternative. Unfortunately, the selection of the most suited combination of anti-microbial compounds necessitates time-consuming trial and error procedures.
IMEnz Bioengineering has a dedicated prior art system that can be exploited to discover and validate anti-microbial compounds. The system is fast and capable of assessing effective doses of combinations of microbial growth-affecting agents. By these means it is possible to screen the effect of large numbers of compounds with potential anti-microbial activity in a short time.
“Contrary to simple growth inhibitory experiments, in which effective anti-microbials that yield indirect effects on growth can be masked by other growth characteristics, this sensitive system has the advantage that even such indirect effects can be scored. In particular this relates to the identification of compounds that are potentially effective in combination with other agents in hurdle-technology related approaches” explains Harry Laan CEO of IMEnz Bioengineering.
The novel technology will be of particular interest for feed, food and pharmaceutical companies that are seeking for efficient strategies to conquer microbial infections in their production processes or products.
Interested companies are invited to contact IMEnz Bioengineering.
Internships
From September 2006 we have two trainee-positions (internships)
available for biotechnology-, molecular biology-, or biomedical
students.
For more information contact us at research@imenz.com.
IMEnz Bioengineering develops new promising product for fermentation industry
Biotech company IMEnz Bioengineering has developed a new nutrient for the fementation industry. The new product is a plant derived N-source, and it was shown that growth of several industrial micro-organisms increased dramatically compared to several other nutrients commonly used in the fermentation industry. A patent application was filed recently. Harry Laan, managing director of IMEnz Bioengineering states that his product has several advantages: “This product meets the safety demands of the fermentation industry for the coming years: it is 100% vegetable and replaces currently used GMO derived additives and additives of animal origin”.”Moreover, it just works better!”
IMEnz is now offering sample preparations of the product for the fermentation industry to test and compare. Interested industries can contact IMEnz Bioengineering at research@imenz.com or call +31 50 3132025.